{"gene":"MSL3","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2011,"finding":"Crystal structures of binary complexes show that MSL1 recruits MSL3 via an extended chain forming an extensive hydrophobic interface, and recruits MOF via electrostatic interactions between the MOF HAT domain and a long helix of MSL1; selective disruption of these interfaces severely impairs MSL1 targeting to dosage-compensated gene bodies and high-affinity sites without affecting promoter binding, establishing MSL1 as a scaffold for MSL complex assembly.","method":"X-ray crystallography of mammalian MSL3–MSL1 and MOF–MSL1 binary complexes; site-directed mutagenesis of interfaces; ChIP in Drosophila","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus mutagenesis plus in vivo ChIP validation","pmids":["21217699"],"is_preprint":false},{"year":2010,"finding":"The MSL3 chromodomain co-recognizes the DNA minor groove and the H4K20 monomethyl mark via a four-residue aromatic cage; H4K16 acetylation antagonizes MSL3 binding, indicating that MSL spreading is regulated by a combination of histone post-translational modifications.","method":"X-ray crystal structure of ternary MSL3 chromodomain–DNA–H4K20me1 peptide complex; in vitro binding assays","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — atomic structure of ternary complex with in vitro functional validation","pmids":["20657587"],"is_preprint":false},{"year":2008,"finding":"The MSL3 chromodomain is required for the second targeting step of dosage compensation: chromodomain mutants retain binding to chromatin entry sites but fail to spread to active gene bodies; in vitro, these mutants lack preferential affinity for nucleosomes bearing H3K36me3, establishing that the chromodomain reads H3K36me3 to direct spreading.","method":"ChIP-chip analysis of MSL3 chromodomain mutants in Drosophila; in vitro nucleosome binding assays","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo ChIP-chip plus in vitro nucleosome binding with defined mutants","pmids":["19029895"],"is_preprint":false},{"year":2010,"finding":"The human MSL3 chromo-barrel domain structure (2.5 Å) reveals a canonical methyllysine-binding aromatic cage (Tyr-31, Phe-56, Trp-59, Trp-63) that binds preferentially to H4K20me1 and H4K20me2 peptides; Tyr-31→Ala mutation weakens binding in vitro and compromises male survival in Drosophila, confirming functional importance of this interaction.","method":"X-ray crystallography of human MSL3 chromo-barrel domain; peptide binding assays; Drosophila genetics","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus in vitro binding assays plus in vivo mutagenesis","pmids":["20943666"],"is_preprint":false},{"year":2003,"finding":"MOF acetylates MSL-3 at a single lysine residue adjacent to one of its chromodomains; this acetylation regulates MSL-3 interaction with roX2 RNA and its localization to the X chromosome; the deacetylase RPD3 interacts with MSL-3 and can reverse this modification, suggesting a regulated acetylation–deacetylation cycle controls DCC spreading.","method":"RNAi knockdown of individual DCC components in Schneider cells; mass spectrometry identification of acetylation site; co-immunoprecipitation of RPD3; RNA binding assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, MS-identified modification site, RNAi epistasis, RNA binding assays in same study","pmids":["12769850"],"is_preprint":false},{"year":2005,"finding":"The C-terminal MRG domain of MSL3 is required for interaction with MSL1, which in turn activates MOF's nucleosomal histone acetyltransferase activity in vitro and targets MSL3 to the X-chromosomal territory in vivo; nucleic acid binding determinants reside in the separate N-terminal region.","method":"Domain deletion/truncation analysis; in vitro HAT activity assay; immunofluorescence localization in Drosophila","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — defined domain structure, in vitro HAT assay, and in vivo localization with mutants","pmids":["15988010"],"is_preprint":false},{"year":2006,"finding":"Three functionally distinct domains of MSL-3 have separable roles: the MRG domain is required for X-chromosome targeting; the chromo-barrel domain (CBD) is dispensable for targeting but required for male viability and transcriptional upregulation of X-linked genes; the polar region cooperates with the CBD.","method":"Domain deletion mutants expressed in Drosophila; immunofluorescence localization; quantitative RT-PCR of X-linked genes; survival assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — multiple domain mutants with in vivo localization and gene expression readouts","pmids":["16547465"],"is_preprint":false},{"year":2018,"finding":"Pathogenic MSL3 variants in humans disrupt MSL complex assembly and activity, causing a pronounced loss of H4K16ac levels in patient-derived cells; HDAC inhibitor treatment rebalances acetylation and alleviates some molecular and cellular phenotypes, establishing MSL3 as the subunit responsible for MSL complex integrity and bulk H4K16ac in mammals.","method":"Patient-derived cell lines; western blot for H4K16ac; co-immunoprecipitation for complex assembly; transcriptome analysis; HDAC inhibitor rescue experiments","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Co-IP, ChIP/western for H4K16ac, transcriptomics, pharmacological rescue) in human patient cells","pmids":["30224647"],"is_preprint":false},{"year":2022,"finding":"In female Drosophila germline stem cells, Msl3 acts independently of the canonical MSL complex by reading H3K36me3 marks and cooperating with the ATAC acetyltransferase complex to promote transcription of RpS19b, which is required for translation of Rbfox1 and thereby meiotic entry; loss of Msl3 causes germline stem cell differentiation defects.","method":"Drosophila genetics (msl3 null mutants); immunofluorescence; RNA-seq; polysome fractionation; genetic interaction with Set2 and ATAC complex","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with defined pathway placement and molecular readouts, but single study","pmids":["34878097"],"is_preprint":false}],"current_model":"MSL3 is a chromatin reader–scaffold subunit of the MSL dosage compensation complex that uses its chromo-barrel domain to bind H4K20me1/me2 (and H3K36me3 on nucleosomes) to direct spreading of the complex from entry sites to active gene bodies, while its C-terminal MRG domain interacts with MSL1 to stabilize complex assembly and activate MOF's H4K16 acetyltransferase activity; MSL3 itself is regulated by MOF-mediated acetylation at a single lysine near the chromodomain, which controls its interaction with roX RNA and is reversible by the RPD3 deacetylase, and in humans loss-of-function MSL3 mutations disrupt complex assembly and bulk H4K16ac, causing a neurodevelopmental syndrome."},"narrative":{"teleology":[{"year":2003,"claim":"The question of how MSL3 activity is post-translationally regulated was answered by showing that MOF acetylates MSL3 at a single lysine near the chromodomain, modulating its roX2 RNA binding and X-chromosome localization, with RPD3 acting as the opposing deacetylase.","evidence":"RNAi in Schneider cells, mass spectrometry of acetylation site, Co-IP of RPD3, RNA binding assays","pmids":["12769850"],"confidence":"High","gaps":["In vivo dynamics of the acetylation–deacetylation cycle are not resolved","Whether acetylation affects chromodomain histone-mark binding was not tested","Structural basis of how acetylation alters RNA binding is unknown"]},{"year":2005,"claim":"The domain architecture of MSL3 was functionally mapped, establishing that the C-terminal MRG domain mediates MSL1 interaction and is required for MOF nucleosomal HAT activation, while nucleic acid binding maps to the N-terminal region.","evidence":"Domain deletion/truncation analysis; in vitro HAT assay; immunofluorescence in Drosophila","pmids":["15988010"],"confidence":"High","gaps":["Whether the MRG–MSL1 interaction is direct or bridged was not yet resolved at atomic resolution","Functional contribution of the polar region between domains was unclear"]},{"year":2006,"claim":"The question of whether the chromo-barrel domain is needed for X-chromosome targeting versus transcriptional output was resolved: the MRG domain targets MSL3 to the X, whereas the chromo-barrel domain is dispensable for targeting but essential for male viability and X-linked gene upregulation.","evidence":"Domain deletion mutants in Drosophila with immunofluorescence, qRT-PCR, and survival assays","pmids":["16547465"],"confidence":"High","gaps":["The histone mark recognized by the chromo-barrel domain was not yet identified","How the polar region cooperates with the chromo-barrel domain mechanistically remained unclear"]},{"year":2008,"claim":"The molecular basis of MSL complex spreading was established: the MSL3 chromodomain reads H3K36me3 on nucleosomes, enabling spreading from entry sites to active gene bodies, and chromodomain mutations abolish spreading without affecting initial recruitment.","evidence":"ChIP-chip of MSL3 chromodomain mutants in Drosophila; in vitro nucleosome binding assays","pmids":["19029895"],"confidence":"High","gaps":["Whether H3K36me3 binding and H4K20me binding are independent or cooperative events was unclear","How spreading terminates at gene boundaries was not addressed"]},{"year":2010,"claim":"Structural determination of the MSL3 chromo-barrel domain revealed the aromatic cage that binds H4K20me1/me2 and showed that co-recognition of the DNA minor groove creates a composite binding surface; H4K16ac antagonizes binding, establishing a feedback link between MOF product and MSL3 chromatin retention.","evidence":"X-ray crystallography of human MSL3 chromo-barrel domain and ternary MSL3–DNA–H4K20me1 complex; peptide binding assays; Drosophila Y31A mutagenesis","pmids":["20943666","20657587"],"confidence":"High","gaps":["Whether H3K36me3 and H4K20me1 are read simultaneously on the same nucleosome or sequentially is unresolved","Quantitative contribution of DNA co-recognition versus histone-mark recognition in vivo is unmeasured"]},{"year":2011,"claim":"The atomic basis of MSL complex assembly was resolved: MSL1 recruits MSL3 through an extended hydrophobic interface and MOF through electrostatic contacts, and disruption of either interface impairs targeting to dosage-compensated gene bodies.","evidence":"X-ray crystallography of MSL3–MSL1 and MOF–MSL1 binary complexes; site-directed mutagenesis; ChIP in Drosophila","pmids":["21217699"],"confidence":"High","gaps":["Structure of the full pentameric MSL complex including roX RNA was not determined","Whether MSL1-mediated assembly is regulated by MSL3 acetylation status is unknown"]},{"year":2018,"claim":"The relevance of MSL3 to human disease was established: pathogenic MSL3 variants disrupt MSL complex assembly and cause global loss of H4K16ac, defining a neurodevelopmental syndrome that is partially rescuable by HDAC inhibitors.","evidence":"Patient-derived cell lines; western blot for H4K16ac; Co-IP for complex assembly; transcriptomics; HDAC inhibitor rescue","pmids":["30224647"],"confidence":"High","gaps":["Which MSL3 domains are disrupted by specific patient variants was not systematically mapped","Long-term in vivo efficacy of HDAC inhibitor rescue is untested","Whether transcriptomic changes reflect direct MSL complex targets or secondary effects is unresolved"]},{"year":2022,"claim":"An MSL-complex-independent role for Msl3 was uncovered in female Drosophila germline stem cells, where Msl3 reads H3K36me3 and cooperates with the ATAC acetyltransferase complex to promote transcription of RpS19b, linking it to translational control of Rbfox1 and meiotic entry.","evidence":"Drosophila msl3 null mutants; RNA-seq; polysome fractionation; genetic interactions with Set2 and ATAC complex","pmids":["34878097"],"confidence":"Medium","gaps":["Single study; independent confirmation is needed","Whether Msl3–ATAC interaction is direct or chromatin-mediated is unknown","Whether mammalian MSL3 has analogous complex-independent functions is untested"]},{"year":null,"claim":"Key unresolved questions include the structural basis of the full MSL holocomplex with roX RNA, whether H3K36me3 and H4K20me marks are read on the same or adjacent nucleosomes, and how MSL3 acetylation integrates with chromo-barrel-domain histone-mark recognition to regulate complex spreading dynamics.","evidence":"","pmids":[],"confidence":"High","gaps":["No structure of the complete MSL holocomplex with roX RNA exists","Simultaneous versus sequential reading of H3K36me3 and H4K20me1 is unresolved","In vivo kinetics of MSL3 acetylation–deacetylation cycle and its impact on spreading are unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[1,2,3]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[4,5]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1]}],"localization":[{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[2,6,7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,7]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[1,2,3,4,7]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[6,8]}],"complexes":["MSL/DCC complex"],"partners":["MSL1","MOF","RPD3","ROX2"],"other_free_text":[]},"mechanistic_narrative":"MSL3 is a chromatin-reading scaffold subunit of the MSL dosage compensation complex that couples histone-mark recognition to transcriptional upregulation of X-linked genes. Its N-terminal chromo-barrel domain forms an aromatic cage that binds H4K20me1/me2 and co-recognizes DNA, while on nucleosomes it reads H3K36me3 to direct complex spreading from chromatin entry sites to active gene bodies; H4K16 acetylation antagonizes this binding, creating a feedback mechanism [PMID:20657587, PMID:20943666, PMID:19029895]. The C-terminal MRG domain mediates interaction with MSL1, which is required for both X-chromosome targeting and activation of the MOF acetyltransferase on nucleosomal substrates; MOF in turn acetylates MSL3 near its chromodomain to regulate roX RNA binding, and this modification is reversed by the deacetylase RPD3 [PMID:21217699, PMID:15988010, PMID:12769850]. Loss-of-function MSL3 variants in humans disrupt MSL complex assembly and global H4K16 acetylation, causing a neurodevelopmental syndrome that is partially rescued by HDAC inhibitor treatment [PMID:30224647]."},"prefetch_data":{"uniprot":{"accession":"Q8N5Y2","full_name":"MSL complex subunit 3","aliases":["Male-specific lethal 3 homolog","Male-specific lethal-3 homolog 1","Male-specific lethal-3 protein-like 1","MSL3-like 1"],"length_aa":521,"mass_kda":59.8,"function":"Non-catalytic component of the MSL histone acetyltransferase complex, a multiprotein complex that mediates the majority of histone H4 acetylation at 'Lys-16' (H4K16ac), an epigenetic mark that prevents chromatin compaction (PubMed:16227571, PubMed:16543150, PubMed:20018852, PubMed:20657587, PubMed:20943666, PubMed:21217699, PubMed:30224647, PubMed:33837287). The MSL complex is required for chromosome stability and genome integrity by maintaining homeostatic levels of H4K16ac (PubMed:33837287). The MSL complex is also involved in gene dosage by promoting up-regulation of genes expressed by the X chromosome (By similarity). X up-regulation is required to compensate for autosomal biallelic expression (By similarity). The MSL complex also participates in gene dosage compensation by promoting expression of Tsix non-coding RNA (By similarity). Acts as a histone reader that specifically recognizes and binds histone H4 monomethylated at 'Lys-20' (H4K20Me1) in a DNA-dependent manner and is proposed to be involved in chromosomal targeting of the MSL complex (PubMed:20657587, PubMed:20943666). May play a role X inactivation in females (PubMed:21217699)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8N5Y2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MSL3","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"POLR2I","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MSL3","total_profiled":1310},"omim":[{"mim_id":"614802","title":"MSL COMPLEX SUBUNIT 2; MSL2","url":"https://www.omim.org/entry/614802"},{"mim_id":"614801","title":"MSL COMPLEX SUBUNIT 1; MSL1","url":"https://www.omim.org/entry/614801"},{"mim_id":"609912","title":"LYSINE ACETYLTRANSFERASE 8; KAT8","url":"https://www.omim.org/entry/609912"},{"mim_id":"607303","title":"MORTALITY FACTOR 4-LIKE PROTEIN 1; MORF4L1","url":"https://www.omim.org/entry/607303"},{"mim_id":"301032","title":"BASILICATA-AKHTAR SYNDROME; MRXSBA","url":"https://www.omim.org/entry/301032"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MSL3"},"hgnc":{"alias_symbol":[],"prev_symbol":["MSL3L1"]},"alphafold":{"accession":"Q8N5Y2","domains":[{"cath_id":"2.30.30.140","chopping":"14-113","consensus_level":"high","plddt":85.5155,"start":14,"end":113},{"cath_id":"1.10.274.30","chopping":"177-226_245-292_420-513","consensus_level":"high","plddt":89.7123,"start":177,"end":513}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N5Y2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N5Y2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N5Y2-F1-predicted_aligned_error_v6.png","plddt_mean":68.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MSL3","jax_strain_url":"https://www.jax.org/strain/search?query=MSL3"},"sequence":{"accession":"Q8N5Y2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N5Y2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N5Y2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N5Y2"}},"corpus_meta":[{"pmid":"21217699","id":"PMC_21217699","title":"Structural basis for MOF and MSL3 recruitment into the dosage compensation complex by MSL1.","date":"2011","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21217699","citation_count":95,"is_preprint":false},{"pmid":"19029895","id":"PMC_19029895","title":"The MSL3 chromodomain directs a key targeting step for dosage compensation of the Drosophila melanogaster X chromosome.","date":"2008","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19029895","citation_count":93,"is_preprint":false},{"pmid":"20657587","id":"PMC_20657587","title":"Corecognition of DNA and a methylated histone tail by the MSL3 chromodomain.","date":"2010","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20657587","citation_count":81,"is_preprint":false},{"pmid":"12207710","id":"PMC_12207710","title":"Disruption of msl3 abolishes the synthesis of mycolipanoic and mycolipenic acids required for polyacyltrehalose synthesis in Mycobacterium tuberculosis H37Rv and causes cell aggregation.","date":"2002","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12207710","citation_count":72,"is_preprint":false},{"pmid":"12769850","id":"PMC_12769850","title":"MOF-regulated acetylation of MSL-3 in the Drosophila dosage compensation complex.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12769850","citation_count":66,"is_preprint":false},{"pmid":"15988010","id":"PMC_15988010","title":"The MRG domain mediates the functional integration of MSL3 into the dosage compensation complex.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15988010","citation_count":48,"is_preprint":false},{"pmid":"20943666","id":"PMC_20943666","title":"Structural and biochemical studies on the chromo-barrel domain of male specific lethal 3 (MSL3) reveal a binding preference for mono- or dimethyllysine 20 on histone H4.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20943666","citation_count":37,"is_preprint":false},{"pmid":"30224647","id":"PMC_30224647","title":"De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.","date":"2018","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30224647","citation_count":32,"is_preprint":false},{"pmid":"16547465","id":"PMC_16547465","title":"X-chromosome targeting and dosage compensation are mediated by distinct domains in MSL-3.","date":"2006","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/16547465","citation_count":32,"is_preprint":false},{"pmid":"10395802","id":"PMC_10395802","title":"Characterization of a novel chromo domain gene in xp22.3 with homology to Drosophila msl-3.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10395802","citation_count":26,"is_preprint":false},{"pmid":"34878097","id":"PMC_34878097","title":"Msl3 promotes germline stem cell differentiation in female Drosophila.","date":"2022","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34878097","citation_count":24,"is_preprint":false},{"pmid":"31245767","id":"PMC_31245767","title":"Genetic and physical interactions between the organellar mechanosensitive ion channel homologs MSL1, MSL2, and MSL3 reveal a role for inter-organellar communication in plant development.","date":"2019","source":"Plant direct","url":"https://pubmed.ncbi.nlm.nih.gov/31245767","citation_count":19,"is_preprint":false},{"pmid":"37847071","id":"PMC_37847071","title":"Loss of function of male-specific lethal 3 (Msl3) does not affect spermatogenesis in rodents.","date":"2023","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/37847071","citation_count":2,"is_preprint":false},{"pmid":"40767387","id":"PMC_40767387","title":"Prolonged Follow-Up in a 30-Year-Old Male With a Novel Pathogenic Variant in MSL3 : A Case Report and a Brief Review of the Literature.","date":"2025","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/40767387","citation_count":1,"is_preprint":false},{"pmid":"36993289","id":"PMC_36993289","title":"Loss Of Chromodomain of Male-Specific Lethal 3 (MSL3) Does Not Affect Spermatogenesis In Rodents.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36993289","citation_count":0,"is_preprint":false},{"pmid":"41216464","id":"PMC_41216464","title":"Two Chinese patients with Basilicata-Akhtar syndrome caused by novel MSL3 variants: a case report and literature review.","date":"2025","source":"Translational pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/41216464","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8223,"output_tokens":2288,"usd":0.029494},"stage2":{"model":"claude-opus-4-6","input_tokens":5602,"output_tokens":2537,"usd":0.137153},"total_usd":0.166647,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"Crystal structures of binary complexes show that MSL1 recruits MSL3 via an extended chain forming an extensive hydrophobic interface, and recruits MOF via electrostatic interactions between the MOF HAT domain and a long helix of MSL1; selective disruption of these interfaces severely impairs MSL1 targeting to dosage-compensated gene bodies and high-affinity sites without affecting promoter binding, establishing MSL1 as a scaffold for MSL complex assembly.\",\n      \"method\": \"X-ray crystallography of mammalian MSL3–MSL1 and MOF–MSL1 binary complexes; site-directed mutagenesis of interfaces; ChIP in Drosophila\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus mutagenesis plus in vivo ChIP validation\",\n      \"pmids\": [\"21217699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The MSL3 chromodomain co-recognizes the DNA minor groove and the H4K20 monomethyl mark via a four-residue aromatic cage; H4K16 acetylation antagonizes MSL3 binding, indicating that MSL spreading is regulated by a combination of histone post-translational modifications.\",\n      \"method\": \"X-ray crystal structure of ternary MSL3 chromodomain–DNA–H4K20me1 peptide complex; in vitro binding assays\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — atomic structure of ternary complex with in vitro functional validation\",\n      \"pmids\": [\"20657587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The MSL3 chromodomain is required for the second targeting step of dosage compensation: chromodomain mutants retain binding to chromatin entry sites but fail to spread to active gene bodies; in vitro, these mutants lack preferential affinity for nucleosomes bearing H3K36me3, establishing that the chromodomain reads H3K36me3 to direct spreading.\",\n      \"method\": \"ChIP-chip analysis of MSL3 chromodomain mutants in Drosophila; in vitro nucleosome binding assays\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo ChIP-chip plus in vitro nucleosome binding with defined mutants\",\n      \"pmids\": [\"19029895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The human MSL3 chromo-barrel domain structure (2.5 Å) reveals a canonical methyllysine-binding aromatic cage (Tyr-31, Phe-56, Trp-59, Trp-63) that binds preferentially to H4K20me1 and H4K20me2 peptides; Tyr-31→Ala mutation weakens binding in vitro and compromises male survival in Drosophila, confirming functional importance of this interaction.\",\n      \"method\": \"X-ray crystallography of human MSL3 chromo-barrel domain; peptide binding assays; Drosophila genetics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus in vitro binding assays plus in vivo mutagenesis\",\n      \"pmids\": [\"20943666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MOF acetylates MSL-3 at a single lysine residue adjacent to one of its chromodomains; this acetylation regulates MSL-3 interaction with roX2 RNA and its localization to the X chromosome; the deacetylase RPD3 interacts with MSL-3 and can reverse this modification, suggesting a regulated acetylation–deacetylation cycle controls DCC spreading.\",\n      \"method\": \"RNAi knockdown of individual DCC components in Schneider cells; mass spectrometry identification of acetylation site; co-immunoprecipitation of RPD3; RNA binding assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, MS-identified modification site, RNAi epistasis, RNA binding assays in same study\",\n      \"pmids\": [\"12769850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The C-terminal MRG domain of MSL3 is required for interaction with MSL1, which in turn activates MOF's nucleosomal histone acetyltransferase activity in vitro and targets MSL3 to the X-chromosomal territory in vivo; nucleic acid binding determinants reside in the separate N-terminal region.\",\n      \"method\": \"Domain deletion/truncation analysis; in vitro HAT activity assay; immunofluorescence localization in Drosophila\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined domain structure, in vitro HAT assay, and in vivo localization with mutants\",\n      \"pmids\": [\"15988010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Three functionally distinct domains of MSL-3 have separable roles: the MRG domain is required for X-chromosome targeting; the chromo-barrel domain (CBD) is dispensable for targeting but required for male viability and transcriptional upregulation of X-linked genes; the polar region cooperates with the CBD.\",\n      \"method\": \"Domain deletion mutants expressed in Drosophila; immunofluorescence localization; quantitative RT-PCR of X-linked genes; survival assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple domain mutants with in vivo localization and gene expression readouts\",\n      \"pmids\": [\"16547465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Pathogenic MSL3 variants in humans disrupt MSL complex assembly and activity, causing a pronounced loss of H4K16ac levels in patient-derived cells; HDAC inhibitor treatment rebalances acetylation and alleviates some molecular and cellular phenotypes, establishing MSL3 as the subunit responsible for MSL complex integrity and bulk H4K16ac in mammals.\",\n      \"method\": \"Patient-derived cell lines; western blot for H4K16ac; co-immunoprecipitation for complex assembly; transcriptome analysis; HDAC inhibitor rescue experiments\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Co-IP, ChIP/western for H4K16ac, transcriptomics, pharmacological rescue) in human patient cells\",\n      \"pmids\": [\"30224647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In female Drosophila germline stem cells, Msl3 acts independently of the canonical MSL complex by reading H3K36me3 marks and cooperating with the ATAC acetyltransferase complex to promote transcription of RpS19b, which is required for translation of Rbfox1 and thereby meiotic entry; loss of Msl3 causes germline stem cell differentiation defects.\",\n      \"method\": \"Drosophila genetics (msl3 null mutants); immunofluorescence; RNA-seq; polysome fractionation; genetic interaction with Set2 and ATAC complex\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined pathway placement and molecular readouts, but single study\",\n      \"pmids\": [\"34878097\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MSL3 is a chromatin reader–scaffold subunit of the MSL dosage compensation complex that uses its chromo-barrel domain to bind H4K20me1/me2 (and H3K36me3 on nucleosomes) to direct spreading of the complex from entry sites to active gene bodies, while its C-terminal MRG domain interacts with MSL1 to stabilize complex assembly and activate MOF's H4K16 acetyltransferase activity; MSL3 itself is regulated by MOF-mediated acetylation at a single lysine near the chromodomain, which controls its interaction with roX RNA and is reversible by the RPD3 deacetylase, and in humans loss-of-function MSL3 mutations disrupt complex assembly and bulk H4K16ac, causing a neurodevelopmental syndrome.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MSL3 is a chromatin-reading scaffold subunit of the MSL dosage compensation complex that couples histone-mark recognition to transcriptional upregulation of X-linked genes. Its N-terminal chromo-barrel domain forms an aromatic cage that binds H4K20me1/me2 and co-recognizes DNA, while on nucleosomes it reads H3K36me3 to direct complex spreading from chromatin entry sites to active gene bodies; H4K16 acetylation antagonizes this binding, creating a feedback mechanism [PMID:20657587, PMID:20943666, PMID:19029895]. The C-terminal MRG domain mediates interaction with MSL1, which is required for both X-chromosome targeting and activation of the MOF acetyltransferase on nucleosomal substrates; MOF in turn acetylates MSL3 near its chromodomain to regulate roX RNA binding, and this modification is reversed by the deacetylase RPD3 [PMID:21217699, PMID:15988010, PMID:12769850]. Loss-of-function MSL3 variants in humans disrupt MSL complex assembly and global H4K16 acetylation, causing a neurodevelopmental syndrome that is partially rescued by HDAC inhibitor treatment [PMID:30224647].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"The question of how MSL3 activity is post-translationally regulated was answered by showing that MOF acetylates MSL3 at a single lysine near the chromodomain, modulating its roX2 RNA binding and X-chromosome localization, with RPD3 acting as the opposing deacetylase.\",\n      \"evidence\": \"RNAi in Schneider cells, mass spectrometry of acetylation site, Co-IP of RPD3, RNA binding assays\",\n      \"pmids\": [\"12769850\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo dynamics of the acetylation–deacetylation cycle are not resolved\",\n        \"Whether acetylation affects chromodomain histone-mark binding was not tested\",\n        \"Structural basis of how acetylation alters RNA binding is unknown\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The domain architecture of MSL3 was functionally mapped, establishing that the C-terminal MRG domain mediates MSL1 interaction and is required for MOF nucleosomal HAT activation, while nucleic acid binding maps to the N-terminal region.\",\n      \"evidence\": \"Domain deletion/truncation analysis; in vitro HAT assay; immunofluorescence in Drosophila\",\n      \"pmids\": [\"15988010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the MRG–MSL1 interaction is direct or bridged was not yet resolved at atomic resolution\",\n        \"Functional contribution of the polar region between domains was unclear\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The question of whether the chromo-barrel domain is needed for X-chromosome targeting versus transcriptional output was resolved: the MRG domain targets MSL3 to the X, whereas the chromo-barrel domain is dispensable for targeting but essential for male viability and X-linked gene upregulation.\",\n      \"evidence\": \"Domain deletion mutants in Drosophila with immunofluorescence, qRT-PCR, and survival assays\",\n      \"pmids\": [\"16547465\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The histone mark recognized by the chromo-barrel domain was not yet identified\",\n        \"How the polar region cooperates with the chromo-barrel domain mechanistically remained unclear\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The molecular basis of MSL complex spreading was established: the MSL3 chromodomain reads H3K36me3 on nucleosomes, enabling spreading from entry sites to active gene bodies, and chromodomain mutations abolish spreading without affecting initial recruitment.\",\n      \"evidence\": \"ChIP-chip of MSL3 chromodomain mutants in Drosophila; in vitro nucleosome binding assays\",\n      \"pmids\": [\"19029895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether H3K36me3 binding and H4K20me binding are independent or cooperative events was unclear\",\n        \"How spreading terminates at gene boundaries was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Structural determination of the MSL3 chromo-barrel domain revealed the aromatic cage that binds H4K20me1/me2 and showed that co-recognition of the DNA minor groove creates a composite binding surface; H4K16ac antagonizes binding, establishing a feedback link between MOF product and MSL3 chromatin retention.\",\n      \"evidence\": \"X-ray crystallography of human MSL3 chromo-barrel domain and ternary MSL3–DNA–H4K20me1 complex; peptide binding assays; Drosophila Y31A mutagenesis\",\n      \"pmids\": [\"20943666\", \"20657587\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether H3K36me3 and H4K20me1 are read simultaneously on the same nucleosome or sequentially is unresolved\",\n        \"Quantitative contribution of DNA co-recognition versus histone-mark recognition in vivo is unmeasured\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The atomic basis of MSL complex assembly was resolved: MSL1 recruits MSL3 through an extended hydrophobic interface and MOF through electrostatic contacts, and disruption of either interface impairs targeting to dosage-compensated gene bodies.\",\n      \"evidence\": \"X-ray crystallography of MSL3–MSL1 and MOF–MSL1 binary complexes; site-directed mutagenesis; ChIP in Drosophila\",\n      \"pmids\": [\"21217699\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structure of the full pentameric MSL complex including roX RNA was not determined\",\n        \"Whether MSL1-mediated assembly is regulated by MSL3 acetylation status is unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The relevance of MSL3 to human disease was established: pathogenic MSL3 variants disrupt MSL complex assembly and cause global loss of H4K16ac, defining a neurodevelopmental syndrome that is partially rescuable by HDAC inhibitors.\",\n      \"evidence\": \"Patient-derived cell lines; western blot for H4K16ac; Co-IP for complex assembly; transcriptomics; HDAC inhibitor rescue\",\n      \"pmids\": [\"30224647\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which MSL3 domains are disrupted by specific patient variants was not systematically mapped\",\n        \"Long-term in vivo efficacy of HDAC inhibitor rescue is untested\",\n        \"Whether transcriptomic changes reflect direct MSL complex targets or secondary effects is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"An MSL-complex-independent role for Msl3 was uncovered in female Drosophila germline stem cells, where Msl3 reads H3K36me3 and cooperates with the ATAC acetyltransferase complex to promote transcription of RpS19b, linking it to translational control of Rbfox1 and meiotic entry.\",\n      \"evidence\": \"Drosophila msl3 null mutants; RNA-seq; polysome fractionation; genetic interactions with Set2 and ATAC complex\",\n      \"pmids\": [\"34878097\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single study; independent confirmation is needed\",\n        \"Whether Msl3–ATAC interaction is direct or chromatin-mediated is unknown\",\n        \"Whether mammalian MSL3 has analogous complex-independent functions is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of the full MSL holocomplex with roX RNA, whether H3K36me3 and H4K20me marks are read on the same or adjacent nucleosomes, and how MSL3 acetylation integrates with chromo-barrel-domain histone-mark recognition to regulate complex spreading dynamics.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structure of the complete MSL holocomplex with roX RNA exists\",\n        \"Simultaneous versus sequential reading of H3K36me3 and H4K20me1 is unresolved\",\n        \"In vivo kinetics of MSL3 acetylation–deacetylation cycle and its impact on spreading are unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [1, 2, 3]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [2, 6, 7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [1, 2, 3, 4, 7]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"complexes\": [\n      \"MSL/DCC complex\"\n    ],\n    \"partners\": [\n      \"MSL1\",\n      \"MOF\",\n      \"RPD3\",\n      \"roX2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}